1Q net profit for CARLSBERG is 37.8millions, increased by 77%. This is the first synergy result after acquired Carlsberg Singapore for RM370mil in the fourth quarter last year.Assuming :-
1Q EPS = 12.38sen
2Q EPS = ??
3Q EPS = ??
4Q EPS = ??
Forecast the future growth by simply multiply 3 of the remaining Q,
Estimated Total EPS = 12.38 X 4 = 49.52sen
Estimated PE = 9.79sen
Estimated Div Yield = 9%
Estimated Div Payout Ratio = 90%
Estimated FV = 11 X 49.52 = RM5.44
Significantly improved earnings from the synergy effect, likely to make CARLSBG even more appealing. However the forecast maybe just too loose but have given great discount in FV by just merely a low enough figure of 11 times of eps.
***********************************************************************************
Carlsberg Malaysia a 'buy': Maybank
Carlsberg Brewery Malaysia Bhd, the nation’s biggest brewery, was raised to “buy” from “hold” at Maybank Investment Bank Bhd, after first quarter profit jumped 77 per cent from a year earlier.
The share price estimate was increased to RM5.50 from RM4.60, Maybank Investment said in a report today. -- Bloomberg
6 comments:
Today market soar more than 15pts, portfolio increase further stake of Manulife and konsorf, Bought more Manulife at 2.60 and konsorf at 1.23.
Update portfolio + Ultramargin line
1. Kfima 100% (cost: 95sen)
2. Manulife 55% (cost 2.62)
3. Konsorf 19.8% (cost 1.23)
4. PJ devel 19.6% (cost 73sen)
5. Emivest 12% (cost 62sen)
6. Maxis 8.9% (cost 5.25)
7. MWE 8.1% (cost 94.5sen)
8. OKA 5.2% (cost 60.3sen)
Second portfolio + margin line
1. CCM duopharma 35% (cost 2.40)
2. kfima 35% (cost 91.5sen)
2. Chuan 16.2% (cost 60.5sen)
3. Classic scenic 10% (cost 74.5sen
Update portfolio + Ultramargin line
1. Kfima 100% (cost: 95sen)
2. Manulife 55% (cost 2.62)
3. PJ devel 19.6% (cost 73sen)
4. Konsorf 9.4% (cost 1.23)
5. Maxis 8.9% (cost 5.25)
6. MWE 8.1% (cost 94.5sen)
7. Emivest 5.9% (cost 62sen)
8. OKA 5.2% (cost 60.3sen)
Second portfolio + margin line
1. CCM duopharma 31% (cost 2.40)
2. kfima 35% (cost 91.5sen)
2. Chuan 16.2% (cost 60.5sen)
3. Classic scenic 10% (cost 74.5sen
Update portfolio + Ultramargin line
1. Kfima 100% (cost: 95sen)
2. Manulife 64% (cost 2.62)
3. PJ devel 19.6% (cost 73sen)
4. Maxis 8.9% (cost 5.25)
5. MWE 8.1% (cost 94.5sen)
6. OKA 5.2% (cost 60.3sen)
7. Konsorf 4.5% (cost 1.23
8. Emivest 3.3% (cost 62sen)
Second portfolio + margin line
1. kfima 35% (cost 91.5sen)
2. CCM duopharma 28% (cost 2.40)
2. Chuan 16.2% (cost 60.5sen)
3. Classic scenic 10% (cost 74.5sen
Update portfolio + Ultramargin line
1. Manulife 108% (cost 2.61)
2. Kfima 100% (cost: 95sen)
3. PJ devel 19.6% (cost 73sen)
4. Maxis 8.9% (cost 5.25)
5. MWE 8.1% (cost 94.5sen)
6. OKA 5.2% (cost 60.3sen)
Second portfolio + margin line
1. CCM duopharma 17% (cost 2.40)
2. Chuan 16.2% (cost 60.5sen)
3. Classic scenic 10% (cost 74.5sen
hng,
noticed that every day also there is buying & selling from yr portfolio.
so fast selling kfima away?
I've sold off all kfima in second portfolio at cost of 91.5sen, sold at 93.5sen yesterday, realize quick profit and to maintain second portfolio lean.
Post a Comment